HHS streamlines 340B dispute process to hospitals’ applause, pharma’s disappointment
The Biden administration has put the finishing touches on the steps entities covered under the 340B Drug Discount Program must take to resolve disputes with drug manufacturers. | A final rule issued this week, among other changes, makes the administrative dispute resolution process more accessible for smaller covered entities.